SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M)+ chemotherapy (C) versus trastuzumab (T)+ C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC …Hope S Rugo,Seock-Ah Im,Gail Lynn Shaw Wright,Santiago Escriva-de-Romani,Michelino DeLaurentiis,Javier Cortes,Shakeela Wazeen Bahadur,Barbara B Haley, Raul H Oyola,David A Riseberg,Antonino Musolino,Fatima Cardoso,Giuseppe Curigliano,Peter A Kaufman,Mark D Pegram,Sutton Edlich,Sam Hong,Edwin P Rock,William John Gradisharuser-5d54d8d2530c705f51c2f7fc（2019）引用 67|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
